Nitin A Pagedar1, Asitha Jayawardena2, Mary E Charlton3, Henry T Hoffman4. 1. Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA nitin-pagedar@uiowa.edu. 2. Department of Otolaryngology, Vanderbilt University, Nashville, Tennessee, USA. 3. Department of Epidemiology, University of Iowa, Iowa City, Iowa, USA. 4. Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA.
Abstract
BACKGROUND: Recent guidelines recommend chest computed tomography (CT) for smokers based on studies of individuals aged 55 to 74 years with 30-pack year smoking to detect lung cancers. Some have postulated that a prior diagnosis of head and neck cancer (HNC) should also warrant lung cancer screening with CT, but no studies have demonstrated benefit in this population. Our goal was to compare survival of HNC patients with second primary lung cancers (SPLCs) with survival of lung cancer-only patients to determine if detecting early stage lung cancer in those with prior HNC could lead to similar survival benefits. METHODS: Survival estimates for patients with early stage SPLC diagnosed between ages 55 and 74 at least 1 year after HNC diagnosis were compared with patients with early stage lung cancer and no other cancers. RESULTS: Median survival of patients with lung cancer only was 38 months. Median survival after SPLC was 22 months. History of head and neck cancer predicted poorer survival after lung cancer diagnosis, P<.0001. CONCLUSIONS: Survival outcomes after early lung cancer are worse after HNC. This finding diminishes the effectiveness of chest CT as a screening modality for HNC survivors, and further study should be undertaken prior to its routine use.
BACKGROUND: Recent guidelines recommend chest computed tomography (CT) for smokers based on studies of individuals aged 55 to 74 years with 30-pack year smoking to detect lung cancers. Some have postulated that a prior diagnosis of head and neck cancer (HNC) should also warrant lung cancer screening with CT, but no studies have demonstrated benefit in this population. Our goal was to compare survival of HNC patients with second primary lung cancers (SPLCs) with survival of lung cancer-only patients to determine if detecting early stage lung cancer in those with prior HNC could lead to similar survival benefits. METHODS: Survival estimates for patients with early stage SPLC diagnosed between ages 55 and 74 at least 1 year after HNC diagnosis were compared with patients with early stage lung cancer and no other cancers. RESULTS: Median survival of patients with lung cancer only was 38 months. Median survival after SPLC was 22 months. History of head and neck cancer predicted poorer survival after lung cancer diagnosis, P<.0001. CONCLUSIONS: Survival outcomes after early lung cancer are worse after HNC. This finding diminishes the effectiveness of chest CT as a screening modality for HNC survivors, and further study should be undertaken prior to its routine use.
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Vijayvel Jayaprakash; Cheng Cheng; Mary Reid; Elisabeth U Dexter; Chukwumere E Nwogu; Wesley Hicks; Maureen Sullivan; Todd L Demmy; Sai Yendamuri Journal: Ann Thorac Surg Date: 2011-09 Impact factor: 4.330
Authors: Rajesh P Dikshit; Paolo Boffetta; Christine Bouchardy; Franco Merletti; Paolo Crosignani; Teresa Cuchi; Eva Ardanaz; Paul Brennan Journal: Cancer Date: 2005-06-01 Impact factor: 6.860
Authors: John M Holland; Amir Arsanjani; Benny J Liem; S Christopher Hoffelt; James I Cohen; Kenneth R Stevens Journal: J Laryngol Otol Date: 2002-03 Impact factor: 1.469
Authors: Robert James Cerfolio; Ayesha S Bryant; Ethan Scott; Manisha Sharma; Francisco Robert; Sharon A Spencer; Robert I Garver Journal: Chest Date: 2006-12 Impact factor: 9.410
Authors: Aaron T Seaman; Kimberly Dukes; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Veléz-Bermúdez; Robert J Volk; Nitin A Pagedar Journal: Patient Educ Couns Date: 2018-04-22
Authors: A Carmona-Bayonas; P Jiménez-Fonseca; E Castañón; A Ramchandani-Vaswani; R Sánchez-Bayona; A Custodio; D Calvo-Temprano; J A Virizuela Journal: Clin Transl Oncol Date: 2016-07-21 Impact factor: 3.405
Authors: Darragh F Halpenny; Jane D Cunningham; Niamh M Long; Ramon E Sosa; Michelle S Ginsberg Journal: J Thorac Oncol Date: 2016-05-17 Impact factor: 15.609
Authors: Kimberly Dukes; Aaron T Seaman; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Vélez-Bermúdez; Robert J Volk; Nitin A Pagedar Journal: Ann Otol Rhinol Laryngol Date: 2019-08-13 Impact factor: 1.547
Authors: Yusra F Shao; Seongho Kim; John D Cramer; Dina Farhat; Jeffrey Hotaling; Syed Naweed Raza; George Yoo; Ho-Sheng Lin; Harold Kim; Ammar Sukari; Misako Nagasaka Journal: Head Neck Date: 2022-06-17 Impact factor: 3.821